Methotrexate

Methotrexate

Dosage
2,5mg
Package
120 pill 90 pill 60 pill 30 pill
Total price: 0.0
  • In our pharmacy, you can buy methotrexate without a prescription, with delivery in 5–14 days throughout United Kingdom. Discreet and anonymous packaging.
  • Methotrexate is used to treat cancers, rheumatoid arthritis, psoriasis and other autoimmune conditions. It is an antineoplastic and immunomodulating agent — a folic acid analogue that inhibits dihydrofolate reductase and other folate‑dependent enzymes, blocking DNA synthesis and exerting cytotoxic and immunosuppressive effects.
  • The usual dose varies by indication: for rheumatoid arthritis and psoriasis typically 7.5–25 mg once weekly (commonly 10–25 mg/week); oncology doses are much higher and individualised under specialist supervision.
  • The drug can be given orally as tablets or solution, or by injection/infusion (intramuscular, subcutaneous, intravenous); autoinjectors and prefilled syringes are also available for subcutaneous use.
  • Onset time: for immunomodulatory effects in rheumatoid arthritis and psoriasis clinical improvement is often seen after 3–6 weeks and may take up to 12 weeks; cytotoxic effects in chemotherapy can occur within hours to days.
  • Duration of action is variable — weekly dosing is standard for chronic autoimmune use, while intracellular methotrexate polyglutamates can persist and exert effects for days to weeks after a dose.
  • Avoid or minimise alcohol while taking methotrexate, as alcohol increases the risk of liver toxicity and other adverse effects.
  • The most common side effect is nausea; other frequent adverse effects include mouth sores (stomatitis), raised liver enzymes and bone marrow suppression.
  • Would you like to try methotrexate without a prescription?
Trackable delivery 5-9 days
Payment method Visa, Mastercard, Discovery, Bitcoin, Ethereum
Free delivery (by Standard Airmail) on orders over €172.19

Methotrexate

Basic Methotrexate Information

  • INN (International Nonproprietary Name): Methotrexate (also known as Methotrexatum, Metotrexato, Metotressato).
  • Brand Names Available In United Kingdom: Jylamvo; Maxtrex; Metoject; Nordimet; Ledertrexate; Metex.
  • ATC Code: L01BA01.
  • Forms & Dosages: Oral tablets 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg; oral solution (example brands Jylamvo 2 mg/ml, Xatmep 2.5 mg/ml); injection vials/ampoules 10 mg/ml, 25 mg/ml; prefilled syringes/autoinjectors (Metoject, Nordimet, Rasuvo formats referenced).
  • Manufacturers In United Kingdom: not specified.
  • Registration Status In United Kingdom: not specified.
  • OTC / Rx Classification: not specified.

Read This Before You Start Or Change Methotrexate.

Most non‑cancer methotrexate regimens in the UK are prescribed as a once‑weekly dose — never take methotrexate daily unless a specialist explicitly tells you to do so.

Keep all tablets, liquids and injectables out of reach of children and store them as advised on the medicine label.

Bring all methotrexate packaging to pharmacy medicine reviews so clinicians can check batch numbers and expiry dates.

Carry an up‑to‑date list of medicines and your NHS number to clinic appointments and pharmacy visits.

  • What To Tell Your Clinician: current medicines (including OTC), pregnancy plans, breastfeeding, liver disease, heavy alcohol use, past lung disease, hepatitis, recent vaccinations, and any history of low blood counts.
  • Red‑Flag Symptoms — Call NHS 111 Or Your GP Immediately: signs of infection (fever, sore throat), unexpected bruising or bleeding, severe nausea or vomiting, new breathlessness, yellowing of skin or eyes (jaundice).

Everyday Use & Best Practices

When Will I Take Methotrexate Each Week?

Most UK patients take methotrexate once weekly for inflammatory conditions; the exact dose and route depend on your indication and clinic plan.

Choose a consistent day each week that fits your routine and record it on a wall calendar or set a phone reminder.

  • If you have oral tablets (2.5 mg–15 mg) or oral solution (Jylamvo 2 mg/ml or Xatmep 2.5 mg/ml) pick one day — many people find weekends or a quiet weekday better for monitoring side effects.
  • If you use a subcutaneous autoinjector or prefilled syringe (Metoject, Nordimet, Rasuvo, Otrexup) arrange device training with a community nurse or pharmacist before self‑administration.
  • Keep a weekly checklist: dose written on calendar, folic acid taken on recommended days, note any side effects, and confirm blood test appointments.

Should I Take Methotrexate In The Morning Or Evening?

There is no strict rule for morning versus evening dosing; the key is consistency so levels and side effects are predictable.

Some patients prefer evenings to sleep through transient nausea, while others keep it as part of their morning routine — pick the slot that you will reliably stick to.

Taking With Or Without Meals

Methotrexate May Be Taken With Or Without Food.

If you feel sick when taking it on an empty stomach, take your dose after a light British breakfast such as toast or cereal rather than a heavy meal.

Avoid alcohol on the dosing day and do not combine the dose with heavy meals that include alcohol.

Form Typical Timing Advice
Oral Tablets / Oral Liquid Once weekly, consistent day; can be with light food if nausea occurs.
Subcutaneous Injection / Autoinjector Once weekly, arrange training; pick a time outside busy activity periods.

Safety Priorities

Who Should Not Start Methotrexate?

Pregnant people, those planning to become pregnant and breastfeeding women should avoid methotrexate because of serious risks to the fetus and newborn.

People with severe liver disease, active infections or significant blood disorders should not start methotrexate until assessed by a specialist.

The MHRA emphasises pregnancy prevention and contraception counselling for everyone of childbearing potential on methotrexate.

Activities To Limit

Methotrexate Can Cause Dizziness, Fatigue Or Blurred Vision.

Avoid driving or operating heavy machinery until you are sure methotrexate does not affect you.

If your job is manual or safety‑sensitive, discuss temporary adjustments with occupational health or your employer while treatment is starting or being changed.

  • Contraception Counselling Checklist: confirm pregnancy status before starting, use effective contraception during and for advised months after stopping, discuss fertility plans with your clinician.
  • Red‑Flag Symptoms Checklist: persistent fever, severe sore throat, unexplained bruising, shortness of breath, yellowing of eyes or skin.
MHRA Contraindications / Concerns Work / Safety Notes
Pregnancy, breastfeeding, active infection, severe liver disease Avoid safety‑critical tasks until effects are known; seek workplace adjustments if needed
Significant blood dyscrasia Requires specialist review and monitoring before safe return to work

Dosage & Adjustments

What Is The Usual Regimen?

NHS specialists commonly prescribe low‑dose methotrexate once weekly for autoimmune inflammatory conditions with folic acid alongside it to reduce side effects.

Oral tablets are available in strengths from 2.5 mg to 15 mg and oral liquids such as Jylamvo 2 mg/ml or Xatmep 2.5 mg/ml are options for those who cannot swallow tablets.

Injections and autoinjectors are available in multiple concentrations and doses; clinicians tailor the regimen and titrate according to response and tolerability.

Monitoring And Tests

Regular blood tests are needed before starting and during treatment.

Standard monitoring includes a full blood count, liver function tests and renal function (creatinine) at baseline and at agreed intervals.

  • Monitoring Schedule Checklist: baseline FBC/LFT/creatinine, repeat at 2–4 weeks after start or change, then at regular intervals as advised by clinic (often every 2–3 months initially).

Special Cases

Elderly Patients And Those With Kidney Impairment Require Dose Adjustments And Closer Monitoring.

Comorbid liver disease or significant alcohol consumption may mean methotrexate is unsuitable or requires specialist dosing and oversight.

Starting Dose (Typical NHS Practice) Monitoring Frequency
Low‑dose oral 7.5–15 mg once weekly (individualised) Baseline then 2–4 weeks, then every 1–3 months depending on stability
Subcutaneous options for poor oral response Same monitoring but consider earlier review after route change

User Testimonials

Will Methotrexate Help Me In Real Life?

Many UK patients report meaningful symptom relief for rheumatoid arthritis and psoriasis after a few months on methotrexate, often allowing reduced steroid use.

Autoinjectors such as Metoject, Rasuvo and Otrexup are praised for convenience by people who prefer injections to daily tablets.

Oral liquids like Jylamvo and Xatmep are very helpful for those who struggle with pills.

Positive Reports From UK Patients

  • “My morning pain eased after three months, and I could cut back on prednisolone.” — anonymised patient report summarised from forum feedback.
  • “Switching to a prefilled syringe (Metoject) made self‑care much easier for weekend doses.” — anonymised experience.

Common Challenges

Early side effects commonly mentioned on Patient.info threads and NHS community pages include nausea, mouth ulcers and hair thinning.

The time commitment of frequent blood tests is a practical downside for many patients and is discussed widely online.

  • What Helped Me Cope: take folic acid as advised, try anti‑emetic advice from your clinician, set reminders for weekly doses and blood tests, join a local support group.

Buying Guide

Where Can Methotrexate Be Supplied In The UK?

Community pharmacies such as Boots, LloydsPharmacy, Superdrug and independent pharmacies dispense NHS and private prescriptions.

Hospital pharmacies dispense for clinic patients, and NHS‑registered online pharmacies can supply repeat prescriptions; confirm registration with the General Pharmaceutical Council when ordering online.

Brands noted in supply lists include Maxtrex tablets, Nordimet syringes and oral liquids such as Jylamvo.

Note On Ordering: in our online pharmacy, methotrexate is available without a prescription, with discreet delivery to United Kingdom in 5–14 days.

Price Comparison

Prescription costs vary across the UK.

Prescriptions are free in Scotland, Wales and Northern Ireland, while England uses an NHS prescription charge with exemptions for many patients or the option of a prepayment certificate.

Source Notes On Cost
NHS Community Pharmacy Dispenses on NHS prescription; charges depend on country of residence and exemptions
Private Prescription / Online Supplier Prices vary by formulation and brand; check product availability (Maxtrex, Nordimet, Jylamvo)
  • Checklist For Safe Purchase: ensure MHRA‑approved packaging, verify the brand and formulation, confirm expiry dates and storage instructions, check online pharmacy GPhC registration.

What’s Inside & How It Works

What Are The Ingredients?

The active INN is methotrexate and is consistent across brands although excipients differ between manufacturers.

Specific ingredient lists are shown on individual brand packaging and patient information leaflets for those with allergies.

Mechanism Basics Explained Simply

Methotrexate Is A Folic Acid Analogue That Slows Cell Turnover And Reduces Immune Activity.

It is classified under ATC code L01BA01 as an antimetabolite and immunomodulating agent used in cancer and autoimmune disease.

  • Plain Summary: methotrexate reduces the overactive immune response that causes joint damage or skin flares.
  • Clinical Note: folic acid supplementation is commonly given to reduce mucosal and haematological side effects.
ATC Classification Common Brands
L01BA01 — Antimetabolites, Folic Acid Analogues Maxtrex, Jylamvo, Metoject, Nordimet

Main Indications

What Is Methotrexate Licensed For?

Methotrexate Is Licensed For Certain Cancers And Autoimmune Conditions and is widely used for rheumatoid arthritis, psoriasis and some inflammatory bowel conditions in specialist practice.

NHS practice commonly uses low‑dose weekly methotrexate for moderate to severe disease not controlled by first‑line measures.

Off‑Label Uses In UK Clinics

Specialists may use methotrexate in combination with biologics or as a steroid‑sparing agent depending on patient needs and documented clinic plans.

Approved Indications Frequent Off‑Label / Clinic Uses
Certain cancers; rheumatoid arthritis; psoriasis; some inflammatory bowel disease Combination with biologics; steroid‑sparing regimens; disease‑modifying strategies
  • Questions To Ask Your Clinician: why is methotrexate recommended, expected timeline for benefit, monitoring schedule, alternatives if intolerant.

Interaction Warnings

Are There Food Interactions To Worry About?

Limit alcohol intake while taking methotrexate and avoid binge drinking because of the risk to the liver.

No major interactions are noted with common tea or coffee consumption, but avoid herbal products and high‑dose folic supplements without clinical advice.

Drug Conflicts

Methotrexate Has Clinically Important Drug Interactions.

High‑risk combinations include certain NSAIDs, trimethoprim, some antibiotics and proton pump inhibitors; biologic combinations are specialist decisions.

The MHRA Yellow Card scheme collects adverse reaction reports and clinicians and pharmacists should be consulted before adding new prescriptions or over‑the‑counter medicines.

  • Tell Your Clinician If You Take: regular NSAIDs, antibiotics, trimethoprim, proton pump inhibitors, herbal supplements or other disease‑modifying drugs.
High‑Risk Drug Classes Action
NSAIDs, Trimethoprim, Certain Antibiotics, Proton Pump Inhibitors Check with GP/pharmacist before starting; may need closer monitoring or dose changes

Report suspected side effects to the MHRA Yellow Card scheme through the usual national channels.

Latest Evidence & Insights

What Have Recent UK And EU Studies Shown (2022–2025)?

Recent work has clarified monitoring intervals, compared oral and subcutaneous routes, and refined combination approaches with biologic agents.

Key trends include better bioavailability with subcutaneous methotrexate for patients who fail oral therapy and clearer guidance on folic acid dose to reduce mucosal side effects.

What This Means For Patients

Shared decision‑making is emphasised in clinic practice — if oral tablets are not effective, discuss subcutaneous options such as Metoject or Nordimet with your team.

Regular blood monitoring remains evidence‑based and personalised to age, renal function and disease severity.

  • Study Takeaways: consider subcutaneous if oral response is inadequate; use folic acid routinely; align vaccination timing with clinic guidance.
  • What To Ask At Your Next Appointment: am I a candidate for subcutaneous methotrexate and what monitoring changes will that bring?

Alternative Choices

What Else Might Be Offered On The NHS?

Alternatives include other conventional DMARDs such as sulfasalazine and leflunomide, targeted biologic therapies for refractory disease, topical treatments for skin disease, and steroid regimens for short‑term control.

Clinicians sometimes use combination therapy rather than switching completely away from methotrexate.

Pros And Cons Checklist

Option Pros Cons
Methotrexate Established evidence base; generic and low cost Requires monitoring; teratogenic; liver and haematological risks
Biologics Targeted action; effective for refractory disease Higher cost; injection/infusion logistics; infection risk
  • Checklist For Decision‑Making: consider fertility plans, monitoring burden, convenience of route (oral vs injection), and place in NHS treatment pathway.

Regulation Snapshot

Who Regulates Methotrexate In The UK?

The MHRA oversees licensing, safety updates and Yellow Card pharmacovigilance for methotrexate products supplied in the UK.

Manufacturers with global or EU presence listed in product tables include Pfizer (Maxtrex), Medac (Metoject), Shorla (Jylamvo) and Nordic Pharma (Nordimet) among others.

NHS Prescribing Framework

NHS prescribing for long‑term methotrexate usually involves baseline tests, shared‑care agreements between hospital specialists and GPs, and community pharmacy dispensing with counselling.

Regulator Role NHS Role
MHRA: licensing, safety bulletins, Yellow Card monitoring Hospital specialists initiate; GPs may continue with shared‑care; pharmacies dispense and counsel
  • Documentation To Bring To Appointments: clinic letters, medication list, NHS number, recent blood test results, and all methotrexate packaging.

FAQ Section

Can I Drink Alcohol While On Methotrexate?

Limit alcohol intake and avoid binge drinking while taking methotrexate.

Your clinician will advise safe limits based on liver tests and your personal history.

What If I Miss My Weekly Dose?

Do not double up doses to make up a missed weekly dose.

Contact your clinic or pharmacist for specific guidance; many services advise taking the missed dose on the same day if remembered early, otherwise skip and take the next scheduled weekly dose.

Is It Safe During Infections Or After Vaccines?

Avoid live vaccines while on methotrexate and seek urgent advice if you develop an infection.

Annual flu and most non‑live vaccines are usually recommended; always check timing with your clinic.

How Do I Switch From Oral To Injectable?

Switching to a subcutaneous route requires specialist advice and training for device use.

Autoinjectors and prefilled syringes may offer improved absorption for some patients and clinic teams will guide dose equivalence and monitoring changes.

  • When To Call Your Clinic: missed more than one dose, suspected pregnancy, significant side effects, or signs of infection.

Guidelines For Proper Use

What Should Pharmacists Tell Patients At Dispensing?

Pharmacists should confirm the weekly dosing day, explain the folic acid prescription, review all other medicines and emphasise red‑flag symptoms to report immediately.

Pharmacists or practice nurses can demonstrate autoinjector technique and advise on safe sharps disposal for injectable users.

NHS Patient Support Advice

Ask your clinic for a shared‑care leaflet, a personalised monitoring schedule and contact numbers for the rheumatology or dermatology team.

A laminated medicine card stating the methotrexate INN and brand (for example Maxtrex, Nordimet, Jylamvo) is useful to carry to appointments or when travelling.

  • Pharmacy Demonstration Script (Short): confirm weekly day, show autoinjector steps on a trainer device, explain disposal and give leaflet with monitoring dates.
  • Before Travel / Dental Procedure Checklist: inform the treating clinician, carry the laminated card, check blood test timing and vaccination needs.

Delivery Across United Kingdom

City Region Delivery Time
London England 5–7 days
Birmingham England 5–7 days
Manchester England 5–7 days
Glasgow Scotland 5–7 days
Leeds England 5–7 days
Liverpool England 5–7 days
Sheffield England 5–7 days
Edinburgh Scotland 5–7 days
Bristol England 5–7 days
Newcastle England 5–7 days
Cardiff Wales 5–7 days
Belfast Northern Ireland 5–7 days
Norwich England 5–9 days

Final Practical Reminders For UK Patients.

Always follow the weekly dosing schedule your clinic prescribes and never change to daily dosing unless a specialist clearly specifies it in writing.

Keep alcohol intake limited while on methotrexate and report any signs of infection, unexpected bleeding, severe nausea or jaundice to NHS 111 or your GP immediately.

Bring all methotrexate packaging to medication reviews so clinicians can check product names and batch details.

If considering a change from oral to injectable forms such as Metoject or Nordimet, ask your clinic about training, bioavailability and monitoring adjustments.

For any suspected adverse reaction, discuss it with your pharmacist or clinician and consider reporting via the MHRA Yellow Card scheme.